nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazoxide—ABCC8—ATP sensitive Potassium channels—ABCC9—uterine cancer	0.0374	0.232	CbGpPWpGaD
Diazoxide—KCNJ11—ATP sensitive Potassium channels—ABCC9—uterine cancer	0.0363	0.225	CbGpPWpGaD
Diazoxide—GLUL—oviduct—uterine cancer	0.029	0.0776	CbGeAlD
Diazoxide—KCNMA1—artery—uterine cancer	0.0178	0.0477	CbGeAlD
Diazoxide—ATP1A1—oviduct—uterine cancer	0.0173	0.0462	CbGeAlD
Diazoxide—GLUL—exocrine gland—uterine cancer	0.0168	0.0448	CbGeAlD
Diazoxide—KCNMA1—exocrine gland—uterine cancer	0.0156	0.0415	CbGeAlD
Diazoxide—ATP1A1—exocrine gland—uterine cancer	0.01	0.0267	CbGeAlD
Diazoxide—GLUL—myometrium—uterine cancer	0.00929	0.0248	CbGeAlD
Diazoxide—SLC12A3—renal system—uterine cancer	0.00908	0.0242	CbGeAlD
Diazoxide—KCNMA1—myometrium—uterine cancer	0.00862	0.023	CbGeAlD
Diazoxide—CA2—exocrine gland—uterine cancer	0.00766	0.0205	CbGeAlD
Diazoxide—GLUL—epithelium—uterine cancer	0.00729	0.0195	CbGeAlD
Diazoxide—ABCC8—Inwardly rectifying K+ channels—ABCC9—uterine cancer	0.00728	0.045	CbGpPWpGaD
Diazoxide—SLC12A3—female reproductive system—uterine cancer	0.00727	0.0194	CbGeAlD
Diazoxide—GLUL—uterine cervix—uterine cancer	0.00723	0.0193	CbGeAlD
Diazoxide—KCNJ11—Inwardly rectifying K+ channels—ABCC9—uterine cancer	0.00705	0.0436	CbGpPWpGaD
Diazoxide—GLUL—smooth muscle tissue—uterine cancer	0.00703	0.0188	CbGeAlD
Diazoxide—GLUL—decidua—uterine cancer	0.00689	0.0184	CbGeAlD
Diazoxide—KCNMA1—epithelium—uterine cancer	0.00677	0.0181	CbGeAlD
Diazoxide—GLUL—renal system—uterine cancer	0.00677	0.0181	CbGeAlD
Diazoxide—GLUL—endometrium—uterine cancer	0.00654	0.0175	CbGeAlD
Diazoxide—KCNMA1—smooth muscle tissue—uterine cancer	0.00652	0.0174	CbGeAlD
Diazoxide—ABCC8—ABC-family proteins mediated transport—ABCC9—uterine cancer	0.00646	0.0399	CbGpPWpGaD
Diazoxide—KCNMA1—decidua—uterine cancer	0.00639	0.0171	CbGeAlD
Diazoxide—GLUL—mammalian vulva—uterine cancer	0.00633	0.0169	CbGeAlD
Diazoxide—KCNMA1—renal system—uterine cancer	0.00628	0.0168	CbGeAlD
Diazoxide—ABCC8—smooth muscle tissue—uterine cancer	0.00608	0.0162	CbGeAlD
Diazoxide—GLUL—uterus—uterine cancer	0.00603	0.0161	CbGeAlD
Diazoxide—ABCC8—renal system—uterine cancer	0.00585	0.0156	CbGeAlD
Diazoxide—ABCC8—endometrium—uterine cancer	0.00566	0.0151	CbGeAlD
Diazoxide—KCNMA1—uterus—uterine cancer	0.00559	0.0149	CbGeAlD
Diazoxide—ATP1A1—myometrium—uterine cancer	0.00554	0.0148	CbGeAlD
Diazoxide—GLUL—female reproductive system—uterine cancer	0.00542	0.0145	CbGeAlD
Diazoxide—Drug interaction—Medroxyprogesterone Acetate—uterine cancer	0.00527	0.0114	CcSEcCtD
Diazoxide—Fluid retention—Progesterone—uterine cancer	0.00512	0.011	CcSEcCtD
Diazoxide—KCNJ11—female reproductive system—uterine cancer	0.00509	0.0136	CbGeAlD
Diazoxide—KCNMA1—female reproductive system—uterine cancer	0.00503	0.0134	CbGeAlD
Diazoxide—GLUL—female gonad—uterine cancer	0.00493	0.0132	CbGeAlD
Diazoxide—GLUL—vagina—uterine cancer	0.0049	0.0131	CbGeAlD
Diazoxide—Lightheadedness—Progesterone—uterine cancer	0.00482	0.0104	CcSEcCtD
Diazoxide—CA1—renal system—uterine cancer	0.00477	0.0127	CbGeAlD
Diazoxide—Polyneuropathy—Epirubicin—uterine cancer	0.00474	0.0102	CcSEcCtD
Diazoxide—Fluid retention—Medroxyprogesterone Acetate—uterine cancer	0.00464	0.01	CcSEcCtD
Diazoxide—KCNJ11—female gonad—uterine cancer	0.00463	0.0124	CbGeAlD
Diazoxide—Lymphadenopathy—Progesterone—uterine cancer	0.00459	0.00989	CcSEcCtD
Diazoxide—Polyneuropathy—Doxorubicin—uterine cancer	0.00439	0.00946	CcSEcCtD
Diazoxide—Vascular purpura—Progesterone—uterine cancer	0.00437	0.00943	CcSEcCtD
Diazoxide—ATP1A1—epithelium—uterine cancer	0.00435	0.0116	CbGeAlD
Diazoxide—ATP1A1—uterine cervix—uterine cancer	0.00431	0.0115	CbGeAlD
Diazoxide—ATP1A1—smooth muscle tissue—uterine cancer	0.00419	0.0112	CbGeAlD
Diazoxide—ATP1A1—decidua—uterine cancer	0.00411	0.011	CbGeAlD
Diazoxide—Purpura—Progesterone—uterine cancer	0.00406	0.00875	CcSEcCtD
Diazoxide—KCNMA1—Potassium Channels—ABCC9—uterine cancer	0.00404	0.025	CbGpPWpGaD
Diazoxide—ATP1A1—renal system—uterine cancer	0.00403	0.0108	CbGeAlD
Diazoxide—Diplopia—Progesterone—uterine cancer	0.00391	0.00844	CcSEcCtD
Diazoxide—ATP1A1—endometrium—uterine cancer	0.0039	0.0104	CbGeAlD
Diazoxide—CA1—female reproductive system—uterine cancer	0.00382	0.0102	CbGeAlD
Diazoxide—ATP1A1—mammalian vulva—uterine cancer	0.00377	0.0101	CbGeAlD
Diazoxide—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.00368	0.00793	CcSEcCtD
Diazoxide—ATP1A1—Preimplantation Embryo—HMGA1—uterine cancer	0.0036	0.0223	CbGpPWpGaD
Diazoxide—ATP1A1—uterus—uterine cancer	0.00359	0.0096	CbGeAlD
Diazoxide—Aspartate aminotransferase increased—Progesterone—uterine cancer	0.00352	0.0076	CcSEcCtD
Diazoxide—CA2—epithelium—uterine cancer	0.00333	0.0089	CbGeAlD
Diazoxide—Abdominal discomfort—Progesterone—uterine cancer	0.00324	0.00699	CcSEcCtD
Diazoxide—ATP1A1—female reproductive system—uterine cancer	0.00323	0.00863	CbGeAlD
Diazoxide—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.00323	0.00696	CcSEcCtD
Diazoxide—CA2—smooth muscle tissue—uterine cancer	0.00321	0.00857	CbGeAlD
Diazoxide—GLUL—lymph node—uterine cancer	0.00317	0.00846	CbGeAlD
Diazoxide—CA2—decidua—uterine cancer	0.00315	0.00841	CbGeAlD
Diazoxide—Pain—Carboplatin—uterine cancer	0.00313	0.00675	CcSEcCtD
Diazoxide—CA2—renal system—uterine cancer	0.00309	0.00825	CbGeAlD
Diazoxide—Weight increased—Progesterone—uterine cancer	0.00308	0.00664	CcSEcCtD
Diazoxide—Hyperglycaemia—Progesterone—uterine cancer	0.00305	0.00658	CcSEcCtD
Diazoxide—KCNJ11—lymph node—uterine cancer	0.00298	0.00795	CbGeAlD
Diazoxide—KCNMA1—lymph node—uterine cancer	0.00294	0.00785	CbGeAlD
Diazoxide—ATP1A1—female gonad—uterine cancer	0.00294	0.00785	CbGeAlD
Diazoxide—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00294	0.00633	CcSEcCtD
Diazoxide—ATP1A1—vagina—uterine cancer	0.00292	0.0078	CbGeAlD
Diazoxide—Body temperature increased—Carboplatin—uterine cancer	0.00289	0.00624	CcSEcCtD
Diazoxide—CA2—mammalian vulva—uterine cancer	0.00289	0.00772	CbGeAlD
Diazoxide—ABCC8—Potassium Channels—ABCC9—uterine cancer	0.00287	0.0178	CbGpPWpGaD
Diazoxide—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.00279	0.00601	CcSEcCtD
Diazoxide—KCNJ11—Potassium Channels—ABCC9—uterine cancer	0.00279	0.0172	CbGpPWpGaD
Diazoxide—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00276	0.00596	CcSEcCtD
Diazoxide—Haemoglobin—Progesterone—uterine cancer	0.00272	0.00587	CcSEcCtD
Diazoxide—Haemorrhage—Progesterone—uterine cancer	0.00271	0.00584	CcSEcCtD
Diazoxide—Lacrimation—Epirubicin—uterine cancer	0.00263	0.00567	CcSEcCtD
Diazoxide—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00262	0.00565	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Dactinomycin—uterine cancer	0.00249	0.00537	CcSEcCtD
Diazoxide—CA2—female reproductive system—uterine cancer	0.00248	0.00661	CbGeAlD
Diazoxide—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.00247	0.00532	CcSEcCtD
Diazoxide—GLUL—Neuronal System—ABCC9—uterine cancer	0.00245	0.0152	CbGpPWpGaD
Diazoxide—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00245	0.00529	CcSEcCtD
Diazoxide—Lacrimation—Doxorubicin—uterine cancer	0.00243	0.00524	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—STAR—uterine cancer	0.00229	0.0142	CbGpPWpGaD
Diazoxide—CA2—female gonad—uterine cancer	0.00225	0.00601	CbGeAlD
Diazoxide—CA2—vagina—uterine cancer	0.00224	0.00598	CbGeAlD
Diazoxide—CA1—lymph node—uterine cancer	0.00223	0.00597	CbGeAlD
Diazoxide—Vision blurred—Progesterone—uterine cancer	0.00222	0.00479	CcSEcCtD
Diazoxide—Ill-defined disorder—Progesterone—uterine cancer	0.00219	0.00471	CcSEcCtD
Diazoxide—Ileus—Epirubicin—uterine cancer	0.00218	0.00471	CcSEcCtD
Diazoxide—Malaise—Progesterone—uterine cancer	0.00213	0.00458	CcSEcCtD
Diazoxide—Palpitations—Progesterone—uterine cancer	0.00208	0.00449	CcSEcCtD
Diazoxide—Albuminuria—Epirubicin—uterine cancer	0.00207	0.00446	CcSEcCtD
Diazoxide—Scotoma—Epirubicin—uterine cancer	0.00204	0.00439	CcSEcCtD
Diazoxide—Hypertension—Progesterone—uterine cancer	0.00203	0.00439	CcSEcCtD
Diazoxide—Ileus—Doxorubicin—uterine cancer	0.00202	0.00436	CcSEcCtD
Diazoxide—Chest pain—Progesterone—uterine cancer	0.00201	0.00433	CcSEcCtD
Diazoxide—Anxiety—Progesterone—uterine cancer	0.002	0.00431	CcSEcCtD
Diazoxide—Discomfort—Progesterone—uterine cancer	0.00198	0.00427	CcSEcCtD
Diazoxide—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.00427	CcSEcCtD
Diazoxide—Feeling hot—Epirubicin—uterine cancer	0.00197	0.00425	CcSEcCtD
Diazoxide—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00193	0.00415	CcSEcCtD
Diazoxide—Oedema—Progesterone—uterine cancer	0.00192	0.00415	CcSEcCtD
Diazoxide—Albuminuria—Doxorubicin—uterine cancer	0.00192	0.00413	CcSEcCtD
Diazoxide—Glycosuria—Epirubicin—uterine cancer	0.00191	0.00411	CcSEcCtD
Diazoxide—Ageusia—Epirubicin—uterine cancer	0.00191	0.00411	CcSEcCtD
Diazoxide—ATP1A1—lymph node—uterine cancer	0.00189	0.00505	CbGeAlD
Diazoxide—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00407	CcSEcCtD
Diazoxide—Scotoma—Doxorubicin—uterine cancer	0.00188	0.00406	CcSEcCtD
Diazoxide—Tachycardia—Progesterone—uterine cancer	0.00188	0.00405	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—HNF1B—uterine cancer	0.00187	0.0116	CbGpPWpGaD
Diazoxide—Hyperhidrosis—Progesterone—uterine cancer	0.00186	0.00401	CcSEcCtD
Diazoxide—Anorexia—Progesterone—uterine cancer	0.00183	0.00395	CcSEcCtD
Diazoxide—Feeling hot—Doxorubicin—uterine cancer	0.00182	0.00393	CcSEcCtD
Diazoxide—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00182	0.00392	CcSEcCtD
Diazoxide—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.00391	CcSEcCtD
Diazoxide—Hypotension—Progesterone—uterine cancer	0.0018	0.00387	CcSEcCtD
Diazoxide—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00387	CcSEcCtD
Diazoxide—Flushing—Dactinomycin—uterine cancer	0.00178	0.00383	CcSEcCtD
Diazoxide—Ageusia—Doxorubicin—uterine cancer	0.00177	0.00381	CcSEcCtD
Diazoxide—Glycosuria—Doxorubicin—uterine cancer	0.00177	0.00381	CcSEcCtD
Diazoxide—KCNMA1—Neuronal System—ABCC9—uterine cancer	0.00176	0.0109	CbGpPWpGaD
Diazoxide—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00174	0.00376	CcSEcCtD
Diazoxide—Insomnia—Progesterone—uterine cancer	0.00174	0.00375	CcSEcCtD
Diazoxide—Paraesthesia—Progesterone—uterine cancer	0.00173	0.00372	CcSEcCtD
Diazoxide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00368	CcSEcCtD
Diazoxide—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.00367	CcSEcCtD
Diazoxide—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00363	CcSEcCtD
Diazoxide—Lacrimation increased—Epirubicin—uterine cancer	0.00168	0.00362	CcSEcCtD
Diazoxide—Decreased appetite—Progesterone—uterine cancer	0.00167	0.0036	CcSEcCtD
Diazoxide—ATP1A1—Preimplantation Embryo—CDH1—uterine cancer	0.00167	0.0103	CbGpPWpGaD
Diazoxide—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00358	CcSEcCtD
Diazoxide—Pain—Progesterone—uterine cancer	0.00164	0.00355	CcSEcCtD
Diazoxide—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.00351	CcSEcCtD
Diazoxide—Feeling abnormal—Progesterone—uterine cancer	0.00158	0.00342	CcSEcCtD
Diazoxide—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00158	0.0034	CcSEcCtD
Diazoxide—Gastrointestinal pain—Progesterone—uterine cancer	0.00157	0.00339	CcSEcCtD
Diazoxide—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.00337	CcSEcCtD
Diazoxide—Lacrimation increased—Doxorubicin—uterine cancer	0.00155	0.00335	CcSEcCtD
Diazoxide—Ill-defined disorder—Dactinomycin—uterine cancer	0.00155	0.00333	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—CCL2—uterine cancer	0.00154	0.00955	CbGpPWpGaD
Diazoxide—Body temperature increased—Progesterone—uterine cancer	0.00152	0.00328	CcSEcCtD
Diazoxide—Abdominal pain—Progesterone—uterine cancer	0.00152	0.00328	CcSEcCtD
Diazoxide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00327	CcSEcCtD
Diazoxide—Malaise—Dactinomycin—uterine cancer	0.0015	0.00324	CcSEcCtD
Diazoxide—Leukopenia—Dactinomycin—uterine cancer	0.00149	0.00321	CcSEcCtD
Diazoxide—Fluid retention—Epirubicin—uterine cancer	0.00147	0.00316	CcSEcCtD
Diazoxide—CA2—lymph node—uterine cancer	0.00145	0.00387	CbGeAlD
Diazoxide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.0031	CcSEcCtD
Diazoxide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00307	CcSEcCtD
Diazoxide—Hypersensitivity—Progesterone—uterine cancer	0.00142	0.00306	CcSEcCtD
Diazoxide—Discomfort—Dactinomycin—uterine cancer	0.0014	0.00302	CcSEcCtD
Diazoxide—Asthenia—Progesterone—uterine cancer	0.00138	0.00298	CcSEcCtD
Diazoxide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.00297	CcSEcCtD
Diazoxide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.00297	CcSEcCtD
Diazoxide—Pruritus—Progesterone—uterine cancer	0.00136	0.00293	CcSEcCtD
Diazoxide—Oedema—Dactinomycin—uterine cancer	0.00136	0.00293	CcSEcCtD
Diazoxide—Fluid retention—Doxorubicin—uterine cancer	0.00136	0.00293	CcSEcCtD
Diazoxide—Thrombocytopenia—Dactinomycin—uterine cancer	0.00133	0.00287	CcSEcCtD
Diazoxide—Diarrhoea—Progesterone—uterine cancer	0.00132	0.00284	CcSEcCtD
Diazoxide—Lymphadenopathy—Epirubicin—uterine cancer	0.00132	0.00284	CcSEcCtD
Diazoxide—Anorexia—Dactinomycin—uterine cancer	0.0013	0.00279	CcSEcCtD
Diazoxide—Flushing—Etoposide—uterine cancer	0.00129	0.00277	CcSEcCtD
Diazoxide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00277	CcSEcCtD
Diazoxide—Dizziness—Progesterone—uterine cancer	0.00127	0.00274	CcSEcCtD
Diazoxide—ABCC8—Neuronal System—ABCC9—uterine cancer	0.00125	0.00776	CbGpPWpGaD
Diazoxide—Vascular purpura—Epirubicin—uterine cancer	0.00125	0.0027	CcSEcCtD
Diazoxide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.0027	CcSEcCtD
Diazoxide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00266	CcSEcCtD
Diazoxide—Vomiting—Progesterone—uterine cancer	0.00122	0.00264	CcSEcCtD
Diazoxide—Lymphadenopathy—Doxorubicin—uterine cancer	0.00122	0.00262	CcSEcCtD
Diazoxide—KCNJ11—Neuronal System—ABCC9—uterine cancer	0.00122	0.00752	CbGpPWpGaD
Diazoxide—ABCC8—Integration of energy metabolism—STK11—uterine cancer	0.00122	0.00752	CbGpPWpGaD
Diazoxide—Rash—Progesterone—uterine cancer	0.00121	0.00261	CcSEcCtD
Diazoxide—Dermatitis—Progesterone—uterine cancer	0.00121	0.00261	CcSEcCtD
Diazoxide—Headache—Progesterone—uterine cancer	0.0012	0.0026	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—EZH2—uterine cancer	0.0012	0.00742	CbGpPWpGaD
Diazoxide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00257	CcSEcCtD
Diazoxide—Decreased appetite—Dactinomycin—uterine cancer	0.00118	0.00255	CcSEcCtD
Diazoxide—KCNJ11—Integration of energy metabolism—STK11—uterine cancer	0.00118	0.00729	CbGpPWpGaD
Diazoxide—Purpura—Epirubicin—uterine cancer	0.00116	0.00251	CcSEcCtD
Diazoxide—Pain—Dactinomycin—uterine cancer	0.00116	0.00251	CcSEcCtD
Diazoxide—Vascular purpura—Doxorubicin—uterine cancer	0.00116	0.0025	CcSEcCtD
Diazoxide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.00248	CcSEcCtD
Diazoxide—Nausea—Progesterone—uterine cancer	0.00114	0.00246	CcSEcCtD
Diazoxide—Diplopia—Epirubicin—uterine cancer	0.00112	0.00242	CcSEcCtD
Diazoxide—Feeling abnormal—Dactinomycin—uterine cancer	0.00112	0.00242	CcSEcCtD
Diazoxide—Ill-defined disorder—Etoposide—uterine cancer	0.00112	0.00241	CcSEcCtD
Diazoxide—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00111	0.0024	CcSEcCtD
Diazoxide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00239	CcSEcCtD
Diazoxide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00237	CcSEcCtD
Diazoxide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00237	CcSEcCtD
Diazoxide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00235	CcSEcCtD
Diazoxide—Malaise—Etoposide—uterine cancer	0.00109	0.00234	CcSEcCtD
Diazoxide—Leukopenia—Etoposide—uterine cancer	0.00108	0.00233	CcSEcCtD
Diazoxide—Purpura—Doxorubicin—uterine cancer	0.00108	0.00232	CcSEcCtD
Diazoxide—Abdominal pain—Dactinomycin—uterine cancer	0.00107	0.00232	CcSEcCtD
Diazoxide—Body temperature increased—Dactinomycin—uterine cancer	0.00107	0.00232	CcSEcCtD
Diazoxide—Hypertension—Etoposide—uterine cancer	0.00104	0.00224	CcSEcCtD
Diazoxide—Diplopia—Doxorubicin—uterine cancer	0.00104	0.00224	CcSEcCtD
Diazoxide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00223	CcSEcCtD
Diazoxide—Chest pain—Etoposide—uterine cancer	0.00103	0.00221	CcSEcCtD
Diazoxide—Hypokalaemia—Epirubicin—uterine cancer	0.00102	0.0022	CcSEcCtD
Diazoxide—Discomfort—Etoposide—uterine cancer	0.00101	0.00219	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.00101	0.00218	CcSEcCtD
Diazoxide—Hypersensitivity—Dactinomycin—uterine cancer	0.001	0.00216	CcSEcCtD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.001	0.00619	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.001	0.00619	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—NRAS—uterine cancer	0.000979	0.00606	CbGpPWpGaD
Diazoxide—Asthenia—Dactinomycin—uterine cancer	0.000975	0.0021	CcSEcCtD
Diazoxide—Thrombocytopenia—Etoposide—uterine cancer	0.000963	0.00208	CcSEcCtD
Diazoxide—Tachycardia—Etoposide—uterine cancer	0.00096	0.00207	CcSEcCtD
Diazoxide—Eosinophilia—Epirubicin—uterine cancer	0.00096	0.00207	CcSEcCtD
Diazoxide—Hyperhidrosis—Etoposide—uterine cancer	0.000951	0.00205	CcSEcCtD
Diazoxide—Pancreatitis—Epirubicin—uterine cancer	0.000951	0.00205	CcSEcCtD
Diazoxide—Hypokalaemia—Doxorubicin—uterine cancer	0.000945	0.00204	CcSEcCtD
Diazoxide—Anorexia—Etoposide—uterine cancer	0.000938	0.00202	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000935	0.00202	CcSEcCtD
Diazoxide—Diarrhoea—Dactinomycin—uterine cancer	0.00093	0.00201	CcSEcCtD
Diazoxide—Hypotension—Etoposide—uterine cancer	0.000919	0.00198	CcSEcCtD
Diazoxide—Eosinophilia—Doxorubicin—uterine cancer	0.000889	0.00192	CcSEcCtD
Diazoxide—Paraesthesia—Etoposide—uterine cancer	0.000884	0.0019	CcSEcCtD
Diazoxide—Weight increased—Epirubicin—uterine cancer	0.000883	0.0019	CcSEcCtD
Diazoxide—Pancreatitis—Doxorubicin—uterine cancer	0.00088	0.0019	CcSEcCtD
Diazoxide—Hyperglycaemia—Epirubicin—uterine cancer	0.000875	0.00189	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—CDKN2A—uterine cancer	0.00087	0.00538	CbGpPWpGaD
Diazoxide—Vomiting—Dactinomycin—uterine cancer	0.000864	0.00186	CcSEcCtD
Diazoxide—Rash—Dactinomycin—uterine cancer	0.000857	0.00185	CcSEcCtD
Diazoxide—Decreased appetite—Etoposide—uterine cancer	0.000855	0.00184	CcSEcCtD
Diazoxide—GLUL—Metabolism—SRD5A2—uterine cancer	0.000855	0.00529	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—NDUFB11—uterine cancer	0.000855	0.00529	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—KRAS—uterine cancer	0.000843	0.00521	CbGpPWpGaD
Diazoxide—Pain—Etoposide—uterine cancer	0.000841	0.00181	CcSEcCtD
Diazoxide—Sweating—Epirubicin—uterine cancer	0.000829	0.00179	CcSEcCtD
Diazoxide—Haematuria—Epirubicin—uterine cancer	0.000825	0.00178	CcSEcCtD
Diazoxide—Weight increased—Doxorubicin—uterine cancer	0.000817	0.00176	CcSEcCtD
Diazoxide—Feeling abnormal—Etoposide—uterine cancer	0.000811	0.00175	CcSEcCtD
Diazoxide—Hyperglycaemia—Doxorubicin—uterine cancer	0.00081	0.00175	CcSEcCtD
Diazoxide—Nausea—Dactinomycin—uterine cancer	0.000808	0.00174	CcSEcCtD
Diazoxide—Gastrointestinal pain—Etoposide—uterine cancer	0.000805	0.00173	CcSEcCtD
Diazoxide—Haemoglobin—Epirubicin—uterine cancer	0.00078	0.00168	CcSEcCtD
Diazoxide—Abdominal pain—Etoposide—uterine cancer	0.000778	0.00168	CcSEcCtD
Diazoxide—Body temperature increased—Etoposide—uterine cancer	0.000778	0.00168	CcSEcCtD
Diazoxide—Haemorrhage—Epirubicin—uterine cancer	0.000776	0.00167	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—CDKN1B—uterine cancer	0.00077	0.00476	CbGpPWpGaD
Diazoxide—Sweating—Doxorubicin—uterine cancer	0.000767	0.00165	CcSEcCtD
Diazoxide—Haematuria—Doxorubicin—uterine cancer	0.000763	0.00164	CcSEcCtD
Diazoxide—Hypersensitivity—Etoposide—uterine cancer	0.000725	0.00156	CcSEcCtD
Diazoxide—Haemoglobin—Doxorubicin—uterine cancer	0.000722	0.00156	CcSEcCtD
Diazoxide—Flushing—Epirubicin—uterine cancer	0.00072	0.00155	CcSEcCtD
Diazoxide—Haemorrhage—Doxorubicin—uterine cancer	0.000718	0.00155	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—HRAS—uterine cancer	0.000716	0.00443	CbGpPWpGaD
Diazoxide—Asthenia—Etoposide—uterine cancer	0.000706	0.00152	CcSEcCtD
Diazoxide—Pruritus—Etoposide—uterine cancer	0.000696	0.0015	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—EP300—uterine cancer	0.000676	0.00418	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000674	0.00417	CbGpPWpGaD
Diazoxide—Diarrhoea—Etoposide—uterine cancer	0.000673	0.00145	CcSEcCtD
Diazoxide—Flushing—Doxorubicin—uterine cancer	0.000667	0.00144	CcSEcCtD
Diazoxide—Dizziness—Etoposide—uterine cancer	0.000651	0.0014	CcSEcCtD
Diazoxide—Vision blurred—Epirubicin—uterine cancer	0.000637	0.00137	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—NRAS—uterine cancer	0.000633	0.00391	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—AKT1—uterine cancer	0.000632	0.00391	CbGpPWpGaD
Diazoxide—Ill-defined disorder—Epirubicin—uterine cancer	0.000627	0.00135	CcSEcCtD
Diazoxide—Vomiting—Etoposide—uterine cancer	0.000626	0.00135	CcSEcCtD
Diazoxide—Rash—Etoposide—uterine cancer	0.00062	0.00134	CcSEcCtD
Diazoxide—Dermatitis—Etoposide—uterine cancer	0.00062	0.00134	CcSEcCtD
Diazoxide—GLUL—Metabolism—STAR—uterine cancer	0.000618	0.00382	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—AKR1B1—uterine cancer	0.000618	0.00382	CbGpPWpGaD
Diazoxide—Headache—Etoposide—uterine cancer	0.000616	0.00133	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—IRF1—uterine cancer	0.000616	0.00381	CbGpPWpGaD
Diazoxide—Malaise—Epirubicin—uterine cancer	0.000609	0.00131	CcSEcCtD
Diazoxide—Leukopenia—Epirubicin—uterine cancer	0.000605	0.0013	CcSEcCtD
Diazoxide—Palpitations—Epirubicin—uterine cancer	0.000597	0.00129	CcSEcCtD
Diazoxide—Vision blurred—Doxorubicin—uterine cancer	0.000589	0.00127	CcSEcCtD
Diazoxide—Nausea—Etoposide—uterine cancer	0.000584	0.00126	CcSEcCtD
Diazoxide—Hypertension—Epirubicin—uterine cancer	0.000583	0.00126	CcSEcCtD
Diazoxide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	0.000583	0.00361	CbGpPWpGaD
Diazoxide—Ill-defined disorder—Doxorubicin—uterine cancer	0.00058	0.00125	CcSEcCtD
Diazoxide—Chest pain—Epirubicin—uterine cancer	0.000575	0.00124	CcSEcCtD
Diazoxide—Anxiety—Epirubicin—uterine cancer	0.000573	0.00124	CcSEcCtD
Diazoxide—Discomfort—Epirubicin—uterine cancer	0.000568	0.00123	CcSEcCtD
Diazoxide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	0.000565	0.0035	CbGpPWpGaD
Diazoxide—Malaise—Doxorubicin—uterine cancer	0.000564	0.00122	CcSEcCtD
Diazoxide—Leukopenia—Doxorubicin—uterine cancer	0.00056	0.00121	CcSEcCtD
Diazoxide—Palpitations—Doxorubicin—uterine cancer	0.000553	0.00119	CcSEcCtD
Diazoxide—Oedema—Epirubicin—uterine cancer	0.000552	0.00119	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—KRAS—uterine cancer	0.000545	0.00337	CbGpPWpGaD
Diazoxide—Thrombocytopenia—Epirubicin—uterine cancer	0.00054	0.00116	CcSEcCtD
Diazoxide—Hypertension—Doxorubicin—uterine cancer	0.00054	0.00116	CcSEcCtD
Diazoxide—Tachycardia—Epirubicin—uterine cancer	0.000538	0.00116	CcSEcCtD
Diazoxide—CA2—Metabolism—SRD5A2—uterine cancer	0.000536	0.00332	CbGpPWpGaD
Diazoxide—CA2—Metabolism—NDUFB11—uterine cancer	0.000536	0.00332	CbGpPWpGaD
Diazoxide—Hyperhidrosis—Epirubicin—uterine cancer	0.000533	0.00115	CcSEcCtD
Diazoxide—Chest pain—Doxorubicin—uterine cancer	0.000532	0.00115	CcSEcCtD
Diazoxide—Anxiety—Doxorubicin—uterine cancer	0.000531	0.00114	CcSEcCtD
Diazoxide—Discomfort—Doxorubicin—uterine cancer	0.000526	0.00113	CcSEcCtD
Diazoxide—Anorexia—Epirubicin—uterine cancer	0.000526	0.00113	CcSEcCtD
Diazoxide—Hypotension—Epirubicin—uterine cancer	0.000515	0.00111	CcSEcCtD
Diazoxide—CA1—Metabolism—SRD5A2—uterine cancer	0.000514	0.00318	CbGpPWpGaD
Diazoxide—CA1—Metabolism—NDUFB11—uterine cancer	0.000514	0.00318	CbGpPWpGaD
Diazoxide—Oedema—Doxorubicin—uterine cancer	0.00051	0.0011	CcSEcCtD
Diazoxide—Thrombocytopenia—Doxorubicin—uterine cancer	0.0005	0.00108	CcSEcCtD
Diazoxide—Insomnia—Epirubicin—uterine cancer	0.000499	0.00108	CcSEcCtD
Diazoxide—Tachycardia—Doxorubicin—uterine cancer	0.000498	0.00107	CcSEcCtD
Diazoxide—Paraesthesia—Epirubicin—uterine cancer	0.000495	0.00107	CcSEcCtD
Diazoxide—Hyperhidrosis—Doxorubicin—uterine cancer	0.000493	0.00106	CcSEcCtD
Diazoxide—Anorexia—Doxorubicin—uterine cancer	0.000486	0.00105	CcSEcCtD
Diazoxide—GLUL—Metabolism—POLD1—uterine cancer	0.000485	0.003	CbGpPWpGaD
Diazoxide—Decreased appetite—Epirubicin—uterine cancer	0.000479	0.00103	CcSEcCtD
Diazoxide—Hypotension—Doxorubicin—uterine cancer	0.000477	0.00103	CcSEcCtD
Diazoxide—Pain—Epirubicin—uterine cancer	0.000472	0.00102	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—HRAS—uterine cancer	0.000463	0.00286	CbGpPWpGaD
Diazoxide—Insomnia—Doxorubicin—uterine cancer	0.000462	0.000995	CcSEcCtD
Diazoxide—Paraesthesia—Doxorubicin—uterine cancer	0.000458	0.000988	CcSEcCtD
Diazoxide—Feeling abnormal—Epirubicin—uterine cancer	0.000454	0.00098	CcSEcCtD
Diazoxide—GLUL—Metabolism—AKR1C1—uterine cancer	0.000454	0.00281	CbGpPWpGaD
Diazoxide—Gastrointestinal pain—Epirubicin—uterine cancer	0.000451	0.000972	CcSEcCtD
Diazoxide—Decreased appetite—Doxorubicin—uterine cancer	0.000444	0.000956	CcSEcCtD
Diazoxide—ABCC8—Metabolism—SRD5A2—uterine cancer	0.000437	0.0027	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—NDUFB11—uterine cancer	0.000437	0.0027	CbGpPWpGaD
Diazoxide—Pain—Doxorubicin—uterine cancer	0.000436	0.000941	CcSEcCtD
Diazoxide—Body temperature increased—Epirubicin—uterine cancer	0.000436	0.00094	CcSEcCtD
Diazoxide—Abdominal pain—Epirubicin—uterine cancer	0.000436	0.00094	CcSEcCtD
Diazoxide—KCNJ11—Metabolism—SRD5A2—uterine cancer	0.000424	0.00262	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—NDUFB11—uterine cancer	0.000424	0.00262	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—PTEN—uterine cancer	0.000422	0.00261	CbGpPWpGaD
Diazoxide—Feeling abnormal—Doxorubicin—uterine cancer	0.000421	0.000907	CcSEcCtD
Diazoxide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000417	0.0009	CcSEcCtD
Diazoxide—Hypersensitivity—Epirubicin—uterine cancer	0.000406	0.000876	CcSEcCtD
Diazoxide—GLUL—Metabolism—RRM2—uterine cancer	0.000404	0.0025	CbGpPWpGaD
Diazoxide—Abdominal pain—Doxorubicin—uterine cancer	0.000403	0.00087	CcSEcCtD
Diazoxide—Body temperature increased—Doxorubicin—uterine cancer	0.000403	0.00087	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—EP300—uterine cancer	0.000402	0.00249	CbGpPWpGaD
Diazoxide—Asthenia—Epirubicin—uterine cancer	0.000396	0.000853	CcSEcCtD
Diazoxide—GLUL—Metabolism—DCN—uterine cancer	0.000393	0.00243	CbGpPWpGaD
Diazoxide—Pruritus—Epirubicin—uterine cancer	0.00039	0.000841	CcSEcCtD
Diazoxide—CA2—Metabolism—STAR—uterine cancer	0.000388	0.0024	CbGpPWpGaD
Diazoxide—CA2—Metabolism—AKR1B1—uterine cancer	0.000388	0.0024	CbGpPWpGaD
Diazoxide—GLUL—Transmission across Chemical Synapses—HRAS—uterine cancer	0.000385	0.00238	CbGpPWpGaD
Diazoxide—Diarrhoea—Epirubicin—uterine cancer	0.000377	0.000814	CcSEcCtD
Diazoxide—Hypersensitivity—Doxorubicin—uterine cancer	0.000376	0.000811	CcSEcCtD
Diazoxide—CA1—Metabolism—AKR1B1—uterine cancer	0.000372	0.0023	CbGpPWpGaD
Diazoxide—CA1—Metabolism—STAR—uterine cancer	0.000372	0.0023	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CYP11A1—uterine cancer	0.00037	0.00229	CbGpPWpGaD
Diazoxide—Asthenia—Doxorubicin—uterine cancer	0.000366	0.000789	CcSEcCtD
Diazoxide—Dizziness—Epirubicin—uterine cancer	0.000365	0.000786	CcSEcCtD
Diazoxide—Pruritus—Doxorubicin—uterine cancer	0.000361	0.000778	CcSEcCtD
Diazoxide—Vomiting—Epirubicin—uterine cancer	0.000351	0.000756	CcSEcCtD
Diazoxide—GLUL—Metabolism—AKR1C3—uterine cancer	0.000349	0.00216	CbGpPWpGaD
Diazoxide—Diarrhoea—Doxorubicin—uterine cancer	0.000349	0.000753	CcSEcCtD
Diazoxide—Rash—Epirubicin—uterine cancer	0.000348	0.00075	CcSEcCtD
Diazoxide—Dermatitis—Epirubicin—uterine cancer	0.000347	0.000749	CcSEcCtD
Diazoxide—Headache—Epirubicin—uterine cancer	0.000346	0.000745	CcSEcCtD
Diazoxide—Dizziness—Doxorubicin—uterine cancer	0.000337	0.000728	CcSEcCtD
Diazoxide—Nausea—Epirubicin—uterine cancer	0.000328	0.000706	CcSEcCtD
Diazoxide—Vomiting—Doxorubicin—uterine cancer	0.000324	0.0007	CcSEcCtD
Diazoxide—Rash—Doxorubicin—uterine cancer	0.000322	0.000694	CcSEcCtD
Diazoxide—Dermatitis—Doxorubicin—uterine cancer	0.000321	0.000693	CcSEcCtD
Diazoxide—Headache—Doxorubicin—uterine cancer	0.00032	0.000689	CcSEcCtD
Diazoxide—ABCC8—Metabolism—AKR1B1—uterine cancer	0.000316	0.00195	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—STAR—uterine cancer	0.000316	0.00195	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—AKR1B1—uterine cancer	0.000306	0.00189	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—STAR—uterine cancer	0.000306	0.00189	CbGpPWpGaD
Diazoxide—CA2—Metabolism—POLD1—uterine cancer	0.000304	0.00188	CbGpPWpGaD
Diazoxide—Nausea—Doxorubicin—uterine cancer	0.000303	0.000653	CcSEcCtD
Diazoxide—GLUL—Neuronal System—HRAS—uterine cancer	0.000295	0.00182	CbGpPWpGaD
Diazoxide—CA1—Metabolism—POLD1—uterine cancer	0.000292	0.0018	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—TP53—uterine cancer	0.000288	0.00178	CbGpPWpGaD
Diazoxide—CA2—Metabolism—AKR1C1—uterine cancer	0.000284	0.00176	CbGpPWpGaD
Diazoxide—CA1—Metabolism—AKR1C1—uterine cancer	0.000273	0.00169	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—STK11—uterine cancer	0.000272	0.00168	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CYP19A1—uterine cancer	0.000272	0.00168	CbGpPWpGaD
Diazoxide—CA2—Metabolism—RRM2—uterine cancer	0.000254	0.00157	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—POLD1—uterine cancer	0.000248	0.00153	CbGpPWpGaD
Diazoxide—CA2—Metabolism—DCN—uterine cancer	0.000246	0.00152	CbGpPWpGaD
Diazoxide—CA1—Metabolism—RRM2—uterine cancer	0.000243	0.0015	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—POLD1—uterine cancer	0.00024	0.00149	CbGpPWpGaD
Diazoxide—CA1—Metabolism—DCN—uterine cancer	0.000236	0.00146	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CYP11A1—uterine cancer	0.000232	0.00143	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—AKR1C1—uterine cancer	0.000232	0.00143	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—AKR1C1—uterine cancer	0.000225	0.00139	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CYP11A1—uterine cancer	0.000222	0.00137	CbGpPWpGaD
Diazoxide—CA2—Metabolism—AKR1C3—uterine cancer	0.000219	0.00135	CbGpPWpGaD
Diazoxide—KCNMA1—Neuronal System—HRAS—uterine cancer	0.000212	0.00131	CbGpPWpGaD
Diazoxide—CA1—Metabolism—AKR1C3—uterine cancer	0.00021	0.0013	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—RRM2—uterine cancer	0.000207	0.00128	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—MTHFR—uterine cancer	0.000204	0.00126	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—DCN—uterine cancer	0.000201	0.00124	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—RRM2—uterine cancer	0.0002	0.00124	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—DCN—uterine cancer	0.000195	0.0012	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—EP300—uterine cancer	0.000192	0.00119	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CYP11A1—uterine cancer	0.000189	0.00117	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CYP11A1—uterine cancer	0.000183	0.00113	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—VEGFA—uterine cancer	0.000182	0.00113	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—NRAS—uterine cancer	0.00018	0.00111	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—AKR1C3—uterine cancer	0.000179	0.0011	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—AKR1C3—uterine cancer	0.000173	0.00107	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CYP19A1—uterine cancer	0.000171	0.00106	CbGpPWpGaD
Diazoxide—CA2—Metabolism—STK11—uterine cancer	0.000171	0.00106	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CYP19A1—uterine cancer	0.000164	0.00101	CbGpPWpGaD
Diazoxide—CA1—Metabolism—STK11—uterine cancer	0.000164	0.00101	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—KRAS—uterine cancer	0.000155	0.000957	CbGpPWpGaD
Diazoxide—ABCC8—Neuronal System—HRAS—uterine cancer	0.000151	0.000932	CbGpPWpGaD
Diazoxide—KCNJ11—Neuronal System—HRAS—uterine cancer	0.000146	0.000904	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PIK3CA—uterine cancer	0.000142	0.00088	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CYP19A1—uterine cancer	0.000139	0.00086	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—STK11—uterine cancer	0.000139	0.00086	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—TP53—uterine cancer	0.000138	0.000851	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—STK11—uterine cancer	0.000135	0.000834	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CYP19A1—uterine cancer	0.000135	0.000834	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—HRAS—uterine cancer	0.000132	0.000814	CbGpPWpGaD
Diazoxide—CA2—Metabolism—MTHFR—uterine cancer	0.000128	0.000793	CbGpPWpGaD
Diazoxide—CA1—Metabolism—MTHFR—uterine cancer	0.000123	0.00076	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—AKT1—uterine cancer	0.000116	0.000719	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PTEN—uterine cancer	0.000114	0.000704	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—EP300—uterine cancer	0.000108	0.000671	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—MTHFR—uterine cancer	0.000105	0.000646	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—MTHFR—uterine cancer	0.000101	0.000627	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PIK3CA—uterine cancer	8.03e-05	0.000496	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PTEN—uterine cancer	7.13e-05	0.000441	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PTEN—uterine cancer	6.84e-05	0.000423	CbGpPWpGaD
Diazoxide—CA2—Metabolism—EP300—uterine cancer	6.8e-05	0.000421	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—AKT1—uterine cancer	6.56e-05	0.000406	CbGpPWpGaD
Diazoxide—CA1—Metabolism—EP300—uterine cancer	6.52e-05	0.000403	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PTEN—uterine cancer	5.81e-05	0.00036	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PTEN—uterine cancer	5.64e-05	0.000349	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—EP300—uterine cancer	5.54e-05	0.000343	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—EP300—uterine cancer	5.38e-05	0.000333	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PIK3CA—uterine cancer	5.03e-05	0.000311	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PIK3CA—uterine cancer	4.82e-05	0.000298	CbGpPWpGaD
Diazoxide—CA2—Metabolism—AKT1—uterine cancer	4.11e-05	0.000254	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PIK3CA—uterine cancer	4.1e-05	0.000254	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PIK3CA—uterine cancer	3.98e-05	0.000246	CbGpPWpGaD
Diazoxide—CA1—Metabolism—AKT1—uterine cancer	3.94e-05	0.000244	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—AKT1—uterine cancer	3.35e-05	0.000207	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—AKT1—uterine cancer	3.25e-05	0.000201	CbGpPWpGaD
